Year: 2011

FDA chemist Cheng Yi Liang was named as a defendant along with his son Andrew Liang in a criminal insider trading complaint. U.S. v. Liang (D. Md. Filed March 29, 2011). The SEC filed a parallel action against the chemist. …

FDA CHEMIST CHARGED FOR SERIAL INSIDER TRADING Read More »

The SEC obtained an emergency order halting the diversion of settlement payments from the Receiver of the Tom Petter’s Ponzi schemes. The money was intended to compensate defrauded investors of the feeder funds. The man who operated the feeder funds …

SEC HALTS FRAUDSTER’S EFFORT TO DIVERT SETTLEMENT FUNDS Read More »